<description>&lt;p&gt;Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence. &lt;/p&gt;</description>

Pathfinders in Biopharma

RBC Capital Markets

Funding the future of retinal health with Eyepoint

SEP 3, 202512 MIN
Pathfinders in Biopharma

Funding the future of retinal health with Eyepoint

SEP 3, 202512 MIN

Description

Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence.